Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-PSMA-11 PET/CT for Recurrent Prostate Cancer
NCT02673151Phase 3Completed
- Sponsor
- Andrei Iagaru
- Start
- May 2017
- Primary completion
- Apr 2018
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 3 trial of gallium ga-68 gozetotide in prostate cancer (PCa), sponsored by Andrei Iagaru. Started May 2017; status: completed.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02673151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673151.